Comparison to efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the treatment of chronic hepatitis C (CHC) in Korea : in Kyeonggi-Incheon province, Peginterferon Effects on CHC Treatment (KIPECT) Study